Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Jumia Technologies AG - ADR (JMIA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Jumia Technologies AG - ADR — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.6 (market cap $30.93B), while Jumia Technologies AG - ADR trades at $5.74 (market cap $773.69M). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 40× Jumia Technologies AG - ADR's market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while Jumia Technologies AG - ADR pays none. Which is the better fit depends on your goals.
| GEHC | JMIA | |
|---|---|---|
Market Cap | $30.93B | $773.69M |
Volume | 5,033,451 | 1,611,098 |
Sector | Health | Consumer Cyclical |
52-Week High | $88.16 | $14.60 |
52-Week Low | $59.48 | $5.69 |
Enterprise Value | $39.39B | $739.34M |
Dividend Yield | 0.23% | — |
Typical Hold Time | — | 29 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
JMIA trades at $5.91, down 3.27% with a bearish technical signal. The company shows improving fundamentals with revenue growth to $189M in 2025 and narrowing losses, though it remains unprofitable with a -27.54% net margin. Recent news highlights operational improvements and a $50M capital raise, while analysts maintain a strong buy consensus with a $12 price target representing significant upside potential.
JMIA presents a high-risk, high-reward opportunity with improving operational metrics and path to profitability, but faces execution risks in African markets. The stock trades at a discount to analyst targets but requires successful execution on cost controls and market expansion to justify valuation. Current technical weakness contrasts with fundamental improvement trends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Jumia Technologies AG - ADR
Jumia Technologies AG is the pan-African e-commerce platform. The company's platform consists of a marketplace, which connects sellers with consumers. Its logistics service enables the shipment and delivery of packages from sellers to consumers, and the company's payment service facilitates transactions among participants active on its platform in selected markets. Jumia generates revenue from Sales of goods, Commissions, Fulfillment, Value-added services, and Marketing & Advertising. Its geographical segments are West Africa, North Africa, East & South Africa, Europe, and United Arab Emirates. The firm generates most of its revenue from the West Africa segment.
Read more on JMIA →
